Skip to main content
. 2011 Jan 4;589(Pt 5):1209–1220. doi: 10.1113/jphysiol.2010.203026

Figure 4. Functional sympatholysis in hypertensive subjects treated with an AT1 receptor blocker.

Figure 4

Summary data showing the changes in muscle oxygenation, FBF and SNA in response to LBNP at rest and during handgrip in hypertensive subjects (n= 7) studied at baseline (no drug), after treatment with irbesartan for 4 weeks and after drug washout for 4 weeks. *P < 0.05 vs. rest; †P < 0.05 vs. no drug or washout.